CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kiguchi, K.
Right arrow Articles by Huberman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kiguchi, K.
Right arrow Articles by Huberman, E.

Cell Growth & Differentiation, Vol 1, Issue 6 259-270, Copyright © 1990 by American Association of Cancer Research


ARTICLES

Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: altered patterns of IMP dehydrogenase expression and activity

K Kiguchi, FR Collart, C Henning-Chubb and E Huberman
Biological and Medical Research Division, Argonne National Laboratory, Illinois 60439-4833.

To study the induction of differentiation in human melanoma cells, we treated 12 melanoma cell lines with mycophenolic acid and tiazofurin, inhibitors of IMP dehydrogenase (IMPDH). In all cell lines studied, both agents inhibited cell growth and increased melanin content. However, the degree of growth inhibition did not necessarily correspond to the increase in melanin content. A detailed analysis of the HO and SK-MEL-131 cell lines indicated that mycophenolic acid and tiazofurin caused a time- and dose-dependent increase in the expression of a series of other maturation markers, including formation of dendrite-like structures, tyrosinase activity, and reactivity with the CF21 monoclonal antibody. The growth inhibition and melanogenesis induced by the IMPDH inhibitors was abrogated by the addition of exogenous guanosine. No such effect was observed after treatment of the cells with phorbol 12-myristate 13-acetate or retinoic acid, two other inducers of differentiation in these cells. The mycophenolic acid- and tiazofurin-treated cells also showed an increased level of IMPDH mRNA and protein, perhaps because of compensation for the inhibitor-mediated decrease in IMPDH activity. In contrast, treatment with phorbol 12-myristate 13-acetate or retinoic acid resulted in decreased levels of IMPDH mRNA and protein. The lack of a consistent pattern of IMPDH expression in the cells treated with IMPDH inhibitors and phorbol 12-myristate 13-acetate or retinoic acid suggests that the altered expression of IMPDH is not a general requirement for the induction of cell differentiation in these cells. Our results also suggest that IMPDH inhibitors may provide a useful approach to circumvent the differentiation block in melanoma.


This article has been cited by other articles:


Home page
BloodHome page
J. J. Gu, L. Santiago, and B. S. Mitchell
Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl
Blood, April 15, 2005; 105(8): 3270 - 3277.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Floryk, S. L. Tollaksen, C. S. Giometti, and E. Huberman
Differentiation of Human Prostate Cancer PC-3 Cells Induced by Inhibitors of Inosine 5'-Monophosphate Dehydrogenase
Cancer Res., December 15, 2004; 64(24): 9049 - 9056.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Semizarov, D. Glesne, A. Laouar, K. Schiebel, and E. Huberman
A lineage-specific protein kinase crucial for myeloid maturation
PNAS, December 22, 1998; 95(26): 15412 - 15417.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Y. Liu, S. A. Bohn, and J. L. Sherley
Inosine-5'-Monophosphate Dehydrogenase Is a Rate-determining Factor for p53-dependent Growth Regulation
Mol. Biol. Cell, January 1, 1998; 9(1): 15 - 28.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
A. G. Zimmermann, K. L. Wright, J. P.- Y. Ting, and B. S. Mitchell
Regulation of Inosine-5'-monophosphate Dehydrogenase Type II Gene Expression in Human T Cells: ROLE FOR A NOVEL 5' PALINDROMIC OCTAMER SEQUENCE
J. Biol. Chem., September 5, 1997; 272(36): 22913 - 22923.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. G. Zimmermann, J. Spychala, and B. S. Mitchell
Characterization of the Human Inosine-5'-monophosphate Dehydrogenase Type II Gene
J. Biol. Chem., March 24, 1995; 270(12): 6808 - 6814.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1990 by the American Association of Cancer Research.